References
- Chen CH, Lee HS, Huang GT, et al (2007). Phenotypic analysis of tumor infiltraring lymphocytes in hepatocellular carcinoma. Hepatogastroenterology, 54, 1529-33.
- Chew V, Tow C, Teo M, et al (2010). Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol, 52, 370-9.
- Fu J, Xu D, Liu Z, et al (2007). Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology, 132, 2328-39. https://doi.org/10.1053/j.gastro.2007.03.102
- Gao Q, Qiu SJ, Fan J, et al (2007). Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol, 25, 2586-93. https://doi.org/10.1200/JCO.2006.09.4565
- Gehring AJ, Ho ZZ, Tan AT, et al (2009). Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology, 137, 682-90. https://doi.org/10.1053/j.gastro.2009.04.045
- International Agency for Research on Cancer (2008). Liver cancer incidence and mortality worldwide in 2008. 2011; http://globocan.iarc.fr/factsheets/cancers/liver.asp.
- Kasper HU, Drebber U, Stippel DL, et al (2009). Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol, 15, 5053-7. https://doi.org/10.3748/wjg.15.5053
- Kobayashi N, Hiraoka N, Yamagami W, et al (2007). FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res, 13, 902-11. https://doi.org/10.1158/1078-0432.CCR-06-2363
- Liakou CI, Narayanan S, Ng Tang D, et al (2007). Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immunity, 7, 10-5.
- Li YW, Qiu SJ, Fan J, et al (2009). Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol, 135, 439-49. https://doi.org/10.1007/s00432-008-0469-0
- Matkowski R, Gisterek I, Halon A, et al (2009). The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res, 29, 2445-51.
- Nakano O, Sato M, Naito Y, et al (2001). Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res, 61, 5132-6.
- Okada K, Komuta K, Hashimoto S, et al (2000). Frequency of apoptosis of tumour-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clin Cancer Res, 6, 3560-4.
- Ohmura Y, Yoshikawa K, Saga S, et al(2008). Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. Oncol Rep, 19, 1265-70.
- Pang YL, Zhang HG, Peng JR, et al (2009). The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunol Immunother, 58, 877-86. https://doi.org/10.1007/s00262-008-0603-5
- Schumacher K, Haensch W, Roefzaad C, et al (2001). Prognostic significance of activated CD8 (+) T cell infiltrations within esophageal carcinomas. Cancer Res, 61, 3932-6.
- Setiady YY, Coccia JA, Park PU (2010). In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol, 40, 780-6. https://doi.org/10.1002/eji.200939613
- Shen X, Li N, Li H, et al (2010). Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage. J Cancer Res Clin Oncol, 136, 1745-54. https://doi.org/10.1007/s00432-010-0833-8
- Shi F, Shi M, Zeng Z, et al (2011). PD-1 and PD-L1 upregulation promotes CD8 T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer, 128, 887-96. https://doi.org/10.1002/ijc.25397
- Shirabe K, Kanematsu T, Matsumata T, et al (1991). Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology, 14, 802-5. https://doi.org/10.1002/hep.1840140510
- Shirabe K, Matsumata T, Maeda T, et al (1995). A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration: a clinicopathological study. Hepatogastroenterology, 42, 996-1001.
- Smyth MJ, Teng MW, Swann J, et al (2006). CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol, 176, 1582-7. https://doi.org/10.4049/jimmunol.176.3.1582
- Smyth MJ, Wallace ME, Nutt SL, et al (2005). Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med, 201, 1973-85. https://doi.org/10.1084/jem.20042280
- Streuss L, Bergmann C, Whiteside TL (2009). Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol, 2, 1469-80.
- Unitt E, Marshall A, Gelson W, et al (2006). Tumor lymphocyte infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol, 45, 178-81. https://doi.org/10.1016/j.jhep.2006.06.005
- Wu K, Kryczek I, Chen L, et al (2009). Kupffer cell suppression of CD8 T cells in human hepatocellular carcinoma ismediated by B7-H1/programmed death-1 interactions. Cancer Res, 69, 8067-75. https://doi.org/10.1158/0008-5472.CAN-09-0901
Cited by
- In Vivo Experimental Study on the Effects of Fluid in Increasing the Efficiency of Radiofrequency Ablation vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5799
- Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis vol.9, pp.5, 2014, https://doi.org/10.1371/journal.pone.0096072
- Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b vol.13, pp.1, 2015, https://doi.org/10.1186/s12967-015-0465-5
- Tumor Infiltrating Lymphocytes in Ovarian Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3635
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells vol.4, pp.1, 2015, https://doi.org/10.1038/srep05177
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer vol.6, pp.1, 2017, https://doi.org/10.1080/2162402X.2016.1264562
- Invariant natural killer T infiltration in neuroblastoma with favorable outcome pp.1437-9813, 2017, https://doi.org/10.1007/s00383-017-4189-x
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy vol.36, pp.10, 2015, https://doi.org/10.1038/aps.2015.41
- Prognostic Utility of Tumor-Infiltrating Lymphocytes in Noncolorectal Gastrointestinal Malignancies pp.1940-2465, 2019, https://doi.org/10.1177/1066896918809460
- Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review vol.18, pp.1, 2018, https://doi.org/10.1186/s12935-018-0624-x
- Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression vol.24, pp.31, 2018, https://doi.org/10.3748/wjg.v24.i31.3500